first trust dsip portfolio Daniel Blong DSIP part 2 , #medicine

Large cardiovascular outcome trials have confirmed that semaglutide (Ozempic) significantly reduces the risk of major adverse cardiovascular events in people with type 2 diabetes

For a person weighing 175 lb (approximately 80 kg), this means daily doses between 250 and 500 micrograms, typically expressed as 0.25 to 0.5 mg

It is a cell-permeable, selective NNMT inhibitor that does not require cofactors for activity

Cyanide Poisoning By Ingestion Or Inhalation A retrospective, uncontrolled study was carried out in 14 subjects who had been exposed to cyanide from sources other than from fire or smoke (i.e., ingestion or inhalation)